During the past decade, Complex Oncology Center-Ruse EOOD conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Complex Oncology Center-Ruse EOOD" #1 collaborator was "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Complex Oncology Center-Ruse EOOD" are "Chemotherapy-induced Thrombocytopenia" (2 trials), "Advanced Cancer" (1 trials), "Colorectal Cancer" (1 trials), "Crohn's Disease" (1 trials) and "Cutaneous Melanoma" (1 trials). Many other conditions were trialed in "Complex Oncology Center-Ruse EOOD" in a lesser frequency.

Most popular intervention types in "Complex Oncology Center-Ruse EOOD" are "Drug" (3 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Romiplostim" (2 trials), "BT-11 1,000 mg" (1 trials), "Binimetinib" (1 trials) and "Encorafenib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Complex Oncology Center-Ruse EOOD" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Complex Oncology Center-Ruse EOOD". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Complex Oncology Center-Ruse EOOD, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Complex Oncology Center-Ruse EOOD, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".